Crescent Capital BDC (CCAP) Expected to Announce Quarterly Earnings on Wednesday

Crescent Capital BDC (NASDAQ:CCAP) is expected to be issuing its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings of $0.44 per share and revenue of $39.83 million for the quarter. Parties are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 26, 2026 at 12:00 PM ET.

Crescent Capital BDC Price Performance

Shares of CCAP stock opened at $13.31 on Monday. The company has a market capitalization of $492.34 million, a PE ratio of 13.58 and a beta of 0.55. The firm has a fifty day simple moving average of $14.37 and a 200-day simple moving average of $14.54. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 1.23. Crescent Capital BDC has a twelve month low of $13.03 and a twelve month high of $19.14.

Analysts Set New Price Targets

A number of brokerages have commented on CCAP. Oppenheimer cut their price objective on shares of Crescent Capital BDC from $20.00 to $19.00 and set an “outperform” rating on the stock in a report on Friday, November 14th. Wells Fargo & Company cut their price target on Crescent Capital BDC from $15.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Friday, November 14th. Keefe, Bruyette & Woods reduced their price target on Crescent Capital BDC from $17.00 to $15.50 and set an “outperform” rating for the company in a report on Friday, November 14th. Wall Street Zen upgraded Crescent Capital BDC from a “sell” rating to a “hold” rating in a research note on Saturday, January 10th. Finally, Zacks Research raised Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a research report on Tuesday, February 10th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $16.38.

Institutional Trading of Crescent Capital BDC

Several institutional investors and hedge funds have recently bought and sold shares of CCAP. Northwestern Mutual Wealth Management Co. acquired a new position in shares of Crescent Capital BDC in the 4th quarter worth approximately $27,000. VPR Management LLC lifted its stake in Crescent Capital BDC by 150.0% during the third quarter. VPR Management LLC now owns 5,000 shares of the company’s stock worth $71,000 after purchasing an additional 3,000 shares during the last quarter. Permanens Capital L.P. bought a new position in Crescent Capital BDC during the third quarter worth $147,000. XTX Topco Ltd acquired a new position in Crescent Capital BDC in the second quarter worth $165,000. Finally, NewEdge Advisors LLC increased its stake in Crescent Capital BDC by 20.2% during the fourth quarter. NewEdge Advisors LLC now owns 12,279 shares of the company’s stock valued at $173,000 after purchasing an additional 2,066 shares during the last quarter. Institutional investors and hedge funds own 49.46% of the company’s stock.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.